New Zubsolv Dosage Strength Coming Soon

New Zubsolv Dosage Strength Coming Soon
New Zubsolv Dosage Strength Coming Soon

Orexo announced its plans to launch Zubsolv (buprenorphine and naloxone) sublingual tablets in a new 8.6mg/2.1mg strength.

Zubsolv is a CIII controlled substance that combines buprenorphine HCl, an opioid (partial agonist-antagonist), and naloxone HCl, an opioid antagonist. It was approved in July 2013 for the maintenance treatment of opioid dependence as part of a complete treatment plan, including counseling and psychosocial support.

RELATED: Orexo Seeks to Expand Zubsolv Labeling

Zubsolv is currently available in 1.4mg/0.36mg and 5.7mg/1.4mg strengths. The new strength is also based on the same proprietary formulation as the existing strengths, offering higher bioavailability and a faster dissolving time.

The new menthol-flavored 8.6mg/2.1mg strength sublingual tablets will be available in the first half of March 2015.

For more information call (855) 982-7658 or visit Zubsolv.com.

Loading links....